Trophic effects of polynucleotides and hyaluronic acid in the healing of venous ulcers of the lower limbs: a clinical study
- PMID: 25224018
- PMCID: PMC7949893
- DOI: 10.1111/iwj.12368
Trophic effects of polynucleotides and hyaluronic acid in the healing of venous ulcers of the lower limbs: a clinical study
Abstract
The aim of this study was to evaluate the results of treatment of venous lower limbs ulcers through the topical application of polynucleotides and hyaluronic acid gel (PNHA): Nucliaskin S™ (Mastelli srl, San Remo, Italy). This study was carried out in 39 consecutive patients who were randomly allocated to two groups: group I (20 patients) received treatment with PNHA (topical gel application two times a week, for a total of 6 weeks); group II (19 patients) received only hyaluronic acid (HA) topical application. All patients received a surgical debridement of the ulcerative lesions before topical treatment with PNHA or HA. Pre-treatment data indicated the area of ulceration. The number of healed ulcers and the variation in area of ulceration were considered as endpoints. The endpoints were observed after 45 days from the beginning of treatment. Complete wound healing occurred in 60% of limbs of group I and in 22% of those of group II patients. The average area reduction was 67% versus 34% in patients of group I and II, respectively. No side effects were recorded in both groups. Our experience shows that PNHA has an elevated trophic effect and speeds the healing rate of venous lower limb ulcers. This treatment may be a valid option in clinical practice.
Keywords: Hyaluronic acid; Lower limbs; PDRN; Polynucleotides; Venous ulcers.
© 2014 The Authors. International Wound Journal © 2014 Medicalhelplines.com Inc and John Wiley & Sons Ltd.
Figures




Similar articles
-
Efficacy and Safety of a Hyaluronic Acid-Containing Cream in the Treatment of Chronic, Venous, or Mixed-Origin Leg Ulcers: A Prospective, Multicenter Randomized Controlled Trial.Wounds. 2021 Nov;33(11):285-289. Epub 2021 Oct 5. Wounds. 2021. PMID: 35025757 Clinical Trial.
-
Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial.Int J Low Extrem Wounds. 2009 Sep;8(3):134-40. doi: 10.1177/1534734609344140. Int J Low Extrem Wounds. 2009. PMID: 19703948 Clinical Trial.
-
A new protocol for the treatment of the chronic venous ulcers of the lower limb.Clin Exp Med. 2012 Mar;12(1):55-60. doi: 10.1007/s10238-011-0136-7. Epub 2011 May 11. Clin Exp Med. 2012. PMID: 21559987 Clinical Trial.
-
Factor XIII in ulcerative leg disease: background and preliminary clinical results.Semin Thromb Hemost. 1996;22(5):445-50. doi: 10.1055/s-2007-999044. Semin Thromb Hemost. 1996. PMID: 8989829 Review.
-
Diabetic wound healing and the case for supplemental treatment with topical insulin.J Foot Surg. 1982 Summer;21(2):117-21. J Foot Surg. 1982. PMID: 7047628 Review. No abstract available.
Cited by
-
The use of acellular porcine dermis, hyaluronic acid and polynucleotides in the treatment of cutaneous ulcers: Single blind randomised clinical trial.Int Wound J. 2020 Dec;17(6):1702-1708. doi: 10.1111/iwj.13454. Epub 2020 Jul 25. Int Wound J. 2020. PMID: 32710584 Free PMC article. Clinical Trial.
-
Polynucleotides in Aesthetic Medicine: A Review of Current Practices and Perceived Effectiveness.Int J Mol Sci. 2024 Jul 27;25(15):8224. doi: 10.3390/ijms25158224. Int J Mol Sci. 2024. PMID: 39125793 Free PMC article. Review.
-
From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs): Bridging the Gap Between Scientific Definitions, Molecular Insights, and Clinical Applications of Multifunctional Biomolecules.Biomolecules. 2025 Jan 19;15(1):148. doi: 10.3390/biom15010148. Biomolecules. 2025. PMID: 39858543 Free PMC article. Review.
-
Pharmacological Activity and Clinical Use of PDRN.Front Pharmacol. 2017 Apr 26;8:224. doi: 10.3389/fphar.2017.00224. eCollection 2017. Front Pharmacol. 2017. PMID: 28491036 Free PMC article. Review.
-
Polynucleotides Enhance Skin Barrier Function and Reduce Inflammation in a 2,4-Dinitrochlorobenzene-Induced Mouse Model of Atopic Dermatitis.Skin Res Technol. 2025 Jun;31(6):e70189. doi: 10.1111/srt.70189. Skin Res Technol. 2025. PMID: 40484710 Free PMC article.
References
-
- Nelzen O, Bergqvist D, Lindhagen A. The prevalence of chronic lower‐limb ulceration has been under estimated: results of a validate population questionnaire. Br J Surg 1996;83:255–8. - PubMed
-
- Baker SR, Stacey MC, Jopp‐McKay AG, Hoskin SE. Epidemiology of chronic venous ulcers. Br J Surg 1991;78:864–7. - PubMed
-
- Serra R, Buffone G, de Franciscis A, Mastrangelo D, Molinari V, Montemurro R, de Franciscis S. A genetic study of chronic venous insufficiency. Ann Vasc Surg 2012;26:636–42. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous